Pancreatic Cancer Research

ResearcherGuangdong Academy of Medical SciencesNo recent work listed

Renpeng Xia

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0002-3751-4630; OpenAlex author ID A5051627891. Sources: OpenAlex.

Their work

Papers
5 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
17
Papers, trials and grants by year

2022: 3 papers · 2023: 2 papers

Papers 5

  1. Extracellular vesicle-packaged circBIRC6 from cancer-associated fibroblasts induce platinum resistance via SUMOylation modulation in pancreatic cancer. Co-author DOI 10.1186/s13046-023-02854-3↗
  2. HNF1A regulates oxaliplatin resistance in pancreatic cancer by targeting 53BP1. Co-author DOI 10.3892/ijo.2023.5493↗
  3. Cancer-associated fibroblast-induced lncRNA UPK1A-AS1 confers platinum resistance in pancreatic cancer via efficient double-strand break repair. Co-author DOI 10.1038/s41388-022-02253-6↗
  4. circFARP1 enables cancer-associated fibroblasts to promote gemcitabine resistance in pancreatic cancer via the LIF/STAT3 axis. First author DOI 10.1186/s12943-022-01501-3↗
  5. circCUL2 induces an inflammatory CAF phenotype in pancreatic ductal adenocarcinoma via the activation of the MyD88-dependent NF-κB signaling pathway. Co-author DOI 10.1186/s13046-021-02237-6↗

Closest collaborators

The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Chonghui Hu · 5 shared papers, 2022–2023 · strength 0.78
  2. Shangyou Zheng · 5 shared papers, 2022–2023 · strength 0.78
  3. Rihua He · 4 shared papers, 2022–2023 · strength 0.63
  4. Xiang Zhang · 2 shared papers, 2022–2023 · strength 0.33
  5. Rufu Chen · 2 shared papers, 2022–2023 · strength 0.31
  6. Zhihua Li · 2 shared papers, 2022 · strength 0.30
  7. Hongcao Lin · 2 shared papers, 2022 · strength 0.29
  8. Quanbo Zhou · 2 shared papers, 2022 · strength 0.29
  9. Rufu Chen · 2 shared papers, 2022 · strength 0.29
  10. Rufu Chen · 1 shared paper, 2023 · strength 0.18
  11. Zhiqiang Fu · 1 shared paper, 2023 · strength 0.16
  12. Yu Zhou · 1 shared paper, 2023 · strength 0.16
  13. Shuxin Sun · 1 shared paper, 2023 · strength 0.16
  14. Yuming Luo · 1 shared paper, 2023 · strength 0.16
  15. Xiang Zhang · 1 shared paper, 2022 · strength 0.15
  16. Guolin Li · 1 shared paper, 2022 · strength 0.15
  17. Xiang Zhang · 1 shared paper, 2022 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.